δ-Opioid receptor as a potential therapeutic target for ischemic stroke

被引:0
|
作者
Kalpana Subedi [1 ]
Hongmin Wang [1 ]
机构
[1] Division of Basic Biomedical Sciences and Center for Brain and Behavior Research, Sanford School of Medicine, University of South Dakota
关键词
agonist; AKT; amyloid precursor protein; BDNF; ischemic stroke; neuroprotection; δ-opioid receptor; p38; MAPK; PI3K; TrkB;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
Ischemic stroke is a global epidemic condition due to an inadequate supply of blood and oxygen to a specific area of brain either by arterial blockage or by narrowing of blood vessels. Despite having advancement in the use of thrombolytic and clot removal medicine, significant numbers of stroke patients are still left out without option for treatment. In this review, we summarize recent research work on the activation of δ-opioid receptor as a strategy for treating ischemic stroke-caused neuronal injury. Moreover, as activation of δ-opioid receptor by a non-peptidic δ-opioid receptor agonist also modulates the expression, maturation and processing of amyloid precursor protein and β-secretase activity, the potential role of these effects on ischemic stroke caused dementia or Alzheimer’s disease are also discussed.
引用
收藏
页码:20 / 24
页数:5
相关论文
共 50 条
  • [21] Trimethylamine-N-oxide: a potential biomarker and therapeutic target in ischemic stroke
    Liu, Yuan
    Qu, Juan
    Xu, Junjie
    Gu, Aiming
    Deng, Dezhi
    Jia, Xiaodan
    Wang, Baoxiang
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [22] Detrimental and Beneficial Effect of Autophagy and a Potential Therapeutic Target after Ischemic Stroke
    Wang, Meng
    Lee, Hangil
    Elkin, Kenneth
    Bardhi, Redina
    Guan, Longfei
    Chandra, Ankush
    Geng, Xiaokun
    Ding, Yuchuan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [23] Blood pressure variability in subacute ischemic stroke A neglected potential therapeutic target
    Tsivgoulis, Georgios
    Ntaios, George
    NEUROLOGY, 2012, 79 (20) : 2014 - 2015
  • [24] Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke
    Meiying Song
    Yuan Zhou
    Xiang Fan
    Molecular Neurobiology, 2022, 59 : 3110 - 3123
  • [25] Opioid antagonists as potential therapeutics for ischemic stroke
    Peyravian, Nadia
    Dikici, Emre
    Deo, Sapna
    Toborek, Michal
    Daunert, Sylvia
    PROGRESS IN NEUROBIOLOGY, 2019, 182
  • [26] Myogenic Tone as a Therapeutic Target for Ischemic Stroke
    Palomares, Sara M.
    Cipolla, Marilyn J.
    CURRENT VASCULAR PHARMACOLOGY, 2014, 12 (06) : 788 - 800
  • [27] PPAR-γ:: therapeutic target for ischemic stroke
    Culman, Juraj
    Zhao, Yi
    Gohlke, Peter
    Herdegen, Thomas
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (05) : 244 - 249
  • [28] Prospects of Therapeutic Target and Directions for Ischemic Stroke
    Kim, Jung Hak
    Kim, So Young
    Kim, Bokyung
    Lee, Sang Rae
    Cha, Sang Hoon
    Lee, Dong Seok
    Lee, Hong Jun
    PHARMACEUTICALS, 2021, 14 (04)
  • [29] Sigma-1 receptor signaling: A potential therapeutic approach for ischemic stroke
    Ngo, Alex
    Fattakhov, Nikolai
    Toborek, Michal
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2024, 44 (12): : 1430 - 1440
  • [30] Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential
    Wu, Yili
    Wang, Xin
    Zhou, Xuan
    Cheng, Baohua
    Li, Gongying
    Bai, Bo
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2017, 10